Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6680
Reference
Drug alert 39/2019
Name
Drug alert class 2 medicines recall no 39 2019: action within 48 hours: PharmaSwiss Česká republika s.r.o. (an affiliate of Bausch & Lomb UK Ltd) Emerade 150, 300 and 500 micrograms solution for injection in pre-filled syringe.
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
PharmaSwiss Česká republika s.r.o. (an affiliate of Bausch & Lomb UK Ltd) is recalling all unexpired batches due an error in one component of the autoinjector believed to cause some pens to fail to activate and deliver adrenaline. Emerade stock held by patients is not being recalled, and patients and caregivers in possession of Emerade pens need to be informed of updated safety information about the risk of failure to activate.
Contact Name
Contact Email
Contact Address
Contact Phone
Created
2019-11-28 00:00:00
Click to go back to homepage